Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allergan Aesthetics, an AbbVie company, is a global leader in the medical aesthetics industry, developing and manufacturing a diverse portfolio of products designed to address various aesthetic and therapeutic needs. The company is best known for its flagship product, Botox Cosmetic (onabotulinumtoxinA), which revolutionized the treatment of facial wrinkles and remains the market leader in neurotoxins. Beyond neurotoxins, Allergan Aesthetics offers the Juvéderm collection of dermal fillers, the CoolSculpting body contouring system, and the SkinMedica professional skincare line. Following its acquisition by AbbVie in 2020, the company continues to operate as a dedicated global business unit focused on innovation in facial aesthetics, body contouring, and regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leading Medical Aesthetics Company.